Cargando…
Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencing
Despite recent therapeutic advances for multiple myeloma (MM), relapse is very common. Here, we conducted longitudinal single-cell transcriptome sequencing (scRNA-seq) of MM cells from a patient with relapsed MM, treated with multiple anti-myeloma drugs. We observed five subclusters of MM cells, whi...
Autores principales: | Masuda, Toru, Haji, Shojiro, Nakashima, Yasuhiro, Tsuda, Mariko, Kimura, Daisaku, Takamatsu, Akiko, Iwahashi, Norifusa, Umakoshi, Hironobu, Shiratsuchi, Motoaki, Kikutake, Chie, Suyama, Mikita, Ohkawa, Yasuyuki, Ogawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386061/ https://www.ncbi.nlm.nih.gov/pubmed/35992084 http://dx.doi.org/10.1016/j.isci.2022.104781 |
Ejemplares similares
-
Pan‐cancer analysis of mutations in open chromatin regions and their possible association with cancer pathogenesis
por: Kikutake, Chie, et al.
Publicado: (2022) -
Pan-cancer analysis of whole-genome doubling and its association with patient prognosis
por: Kikutake, Chie, et al.
Publicado: (2023) -
Possible involvement of silent mutations in cancer pathogenesis and evolution
por: Kikutake, Chie, et al.
Publicado: (2023) -
Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis
por: Kikutake, Chie, et al.
Publicado: (2021) -
Genome-wide identification of exon extension/shrinkage events induced by splice-site-creating mutations
por: Qu, Zhuo, et al.
Publicado: (2022)